Platinum Investment Management LTD Sangamo Therapeutics, Inc Transaction History

Platinum Investment Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$9.38 - $12.48 $208,010 - $276,756	-22,176 Reduced 9.22%	218,336 $2.06 Million
Q2 2020 Aug 06, 2020	SELL	$6.21 - $11.83 $33,086 - $63,030	-5,328 Reduced 2.17%	240,512 $2.16 Million
Q1 2020 May 15, 2020	BUY	$5.05 - $8.85 $250,353 - $438,738	49,575 Added 25.26%	245,840 $1.57 Million
Q4 2019 Feb 13, 2020	BUY	$8.03 - $11.7 $222,270 - $323,856	27,680 Added 16.42%	196,265 $1.64 Million
Q1 2019 May 15, 2019	BUY	$7.72 - $12.81 $230,773 - $382,929	29,893 Added 21.55%	168,585 $1.61 Million
Q4 2018 Feb 14, 2019	BUY	$9.51 - $16.6 $815,881 - $1.42 Million	85,792 Added 162.18%	138,692 $1.59 Million
Q2 2018 Aug 15, 2018	BUY	$13.9 - $19.8 $735,310 - $1.05 Million	52,900 New	52,900 $751,000

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $178M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.